Annovis Bio, Inc. has identified material errors in its financial statements for the periods ended March 31, 2022, June 30, 2022, and September 30, 2022, and will be restating the unaudited financial information. The errors are material and should no longer be relied upon. The company is currently determining the exact amounts and full effect of the errors.